Apogee Therapeutics, Inc. is a pioneering biotechnology firm headquartered in Waltham, Massachusetts, dedicated to advancing biologic therapies for chronic inflammatory disorders, such as atopic dermatitis and chronic obstructive pulmonary disease (COPD). With a strong emphasis on innovative science and a promising pipeline, the company aims to fulfill critical unmet medical needs in immunology, thereby enhancing patient outcomes. As Apogee continues to evolve in the biopharmaceutical landscape, it is strategically positioned for potential growth and impact in the therapeutic development sector.
Click "Analyze" to generate stock analysis
APGE Price Trend and Signals
APGE Option Volumes & Open Interests (aggregated)
APGE Put Call Ratios and IV (aggregated)
APGE Financials
2025-10-29Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-20Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-15Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-13Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.